SG64892A1 - Method for treating hepatitis b carriers with minimal disease - Google Patents

Method for treating hepatitis b carriers with minimal disease

Info

Publication number
SG64892A1
SG64892A1 SG1996005575A SG1996005575A SG64892A1 SG 64892 A1 SG64892 A1 SG 64892A1 SG 1996005575 A SG1996005575 A SG 1996005575A SG 1996005575 A SG1996005575 A SG 1996005575A SG 64892 A1 SG64892 A1 SG 64892A1
Authority
SG
Singapore
Prior art keywords
carriers
treating hepatitis
minimal disease
minimal
disease
Prior art date
Application number
SG1996005575A
Other languages
English (en)
Inventor
John D Baxter
Bruce F Scharschmidt
Original Assignee
Sciclone Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/833,468 external-priority patent/US5308833A/en
Application filed by Sciclone Pharmaceuticals filed Critical Sciclone Pharmaceuticals
Publication of SG64892A1 publication Critical patent/SG64892A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996005575A 1992-02-06 1993-10-28 Method for treating hepatitis b carriers with minimal disease SG64892A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/833,468 US5308833A (en) 1992-02-06 1992-02-06 Method for treating hepatitis B carriers with minimal disease

Publications (1)

Publication Number Publication Date
SG64892A1 true SG64892A1 (en) 1999-05-25

Family

ID=1340654

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005575A SG64892A1 (en) 1992-02-06 1993-10-28 Method for treating hepatitis b carriers with minimal disease

Country Status (5)

Country Link
EP (1) EP0728010A4 (enrdf_load_html_response)
NO (1) NO961685D0 (enrdf_load_html_response)
SG (1) SG64892A1 (enrdf_load_html_response)
TW (1) TW249755B (enrdf_load_html_response)
WO (1) WO1995011688A1 (enrdf_load_html_response)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0731710B1 (en) * 1993-11-05 2003-05-14 Alpha 1 Biomedicals, Inc. Thymosine alpha 1 containing compositions for the treatment of patients having decompensated liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
TW224053B (enrdf_load_html_response) * 1991-09-13 1994-05-21 Paul B Chretien
US5308833A (en) * 1992-02-06 1994-05-03 Sciclone Pharmaceuticals Method for treating hepatitis B carriers with minimal disease

Also Published As

Publication number Publication date
EP0728010A4 (en) 1997-10-01
NO961685L (no) 1996-04-26
TW249755B (enrdf_load_html_response) 1995-06-21
EP0728010A1 (en) 1996-08-28
NO961685D0 (no) 1996-04-26
WO1995011688A1 (en) 1995-05-04

Similar Documents

Publication Publication Date Title
EG19392A (en) Improved method for omprazole symthesis
AP9300593A0 (en) Process
GB9218346D0 (en) Process
HU9203682D0 (en) Methods for diagnosing and treating viral hepatitis
GB9203375D0 (en) Process
GB9009404D0 (en) Pelletisation process
GB9202375D0 (en) Process
SG64892A1 (en) Method for treating hepatitis b carriers with minimal disease
HU9300927D0 (en) Method for hetero-annulation
GB9220068D0 (en) Process
AP9300474A0 (en) Process
PH30891A (en) Method for treating hepatitis b carriers with minimal disease.
GB9201496D0 (en) Process
GB9215438D0 (en) Process
AP9300473A0 (en) Process
ZA938110B (en) Treatment of hepatitis B carriers with minimal disease
IL104351A0 (en) Method for treating mycobacterial infections with rifabutin
RU1785687C (ru) Cпocoб лeчehия глoccaлгии
GB9220526D0 (en) Process
GB9225202D0 (en) Process
GB9224659D0 (en) Nox removal process
GB9210926D0 (en) Nox removal process
GB9214518D0 (en) Carriers
IL123389A (en) Method for purifying trehalose
ZA919247B (en) Treatment method